In addition to the GTP/GDP cycle, small G proteins also cycle between the membrane and the cytosol (
Del Pozo et al., 2002 
). As well as GTP loading, this membrane targeting is required for the initiation of downstream effector signaling (
del Pozo et al., 2004 
). It has been shown that the C termini of small GTPases mediate differential intracellular localization (
Michaelson et al., 2001 
), and it has been demonstrated that the C termini of Rac1 and Rac2 dictate both subcellular localization and differential signaling (
Filippi et al., 2004 
). These results suggest that the localizations of small G proteins to their proper targets are key step for the regulation of small G proteins functions and in this process, C terminus of small GTPase mediates their intracellular targeting. However, little is known about the mechanisms that determine the specificity of the Rac membrane binding site or how the C terminus of Rac is involved in this membrane targeting. The present study demonstrates that the polybasic motif in the C terminus of Rac1 mediates its interaction with PA, which induces Rac1 membrane targeting. In the absence of PLD activity, Rac1 does not translocate to the plasma membrane, and even in the GTP-loaded state, Rac1 does not activate the down stream effector PAK. The direct interaction between PA and the polybasic motif of Rac1 along and our mutant studies suggest that Rac1 membrane targeting is mediated by PA through an interaction with the polybasic motif in the Rac1 C terminus. And we showed that PA can dissociate Rho-GDI from Rac (). Rho-GDI forms complexes with Rac in the cytoplasm, keeping it soluble by shielding the C-terminal hydrophobic isoprenoid moiety of Rac (
Lian et al., 2000 
;
Scheffzek et al., 2000 
). It has also been reported that Rho-GDI overexpression reduced and Rho-GDI down-regulation increased Rac1 membrane targeting (
Michaelson et al., 2001 
). Rho-GDI also blocked the downstream effector binding (
Del Pozo et al., 2002 
). Thus, the release of Rac from Rho-GDI is an important step that allows Rac1 to associate with the membrane and to activate downstream signaling. PA-mediated release of Rho-GDI from Rac can be caused by direct interaction with the C-terminal polybasic region. GDI interacts with the C-terminal isoprenyl region and the PA-binding polybasic region of Rac1 is located beside this isoprenyl region, so this PA–polybasic region interaction may inhibit GDI–isoprenyl group interaction. This notion is supported by the ability of negatively charged lipid to dissociate Rac1 from RhoGDI in vitro (
Chuang et al., 1993 
;
Ugolev et al., 2006 
). And it is reported that prenylated Rac1 mutant, lacking the polybasic region, was found defective in its interaction with Rho-GDI (
Di-Poi et al., 2001 
). These results suggest that these Rac membrane targeting and downstream PAK activation effects may result from the Rho-GDI displacement activity of PA through the direct interaction with polybasic region of Rac. Rac membrane binding sites are within low-density, cholesterol-rich lipid rafts in the plasma membrane (
del Pozo et al., 2004 
), and it has been previously reported that PLD is localized and that its activity is much enhanced in low-density lipid raft regions where Rac1 membrane binding sites are located (
Czarny et al., 1999 
). In fact, during the integrin-mediated cell spreading process, PLD and Rac1 were found to colocalize at cortical regions where polymerized actin is associated with membrane ruffles (A). These results suggest that Rac translocates to PA containing lipid rafts regions in the plasma membrane. Furthermore, this PA mediated Rac translocation can form a positive feedback loop. It is reported that Rac directly interacts with and activates PLD in a GTPγS-dependent manner (
Ohguchi et al., 1997 
;
Powner et al., 2002 
), leading to an increase in the levels of local PA synthesis. Together with the data from this study, recruitment of the GTP-Rac to the PA containing lipid raft where PLD resides would lead to enhanced synthesis of PA.
PA plays a role as a lipid second messenger for recruitment to the membrane of some signaling molecules, such as, Raf-1, p47
phox, and cAMP-PDE4A1. The PA binding sequences in these proteins are composed of multiple basic sequences (
Andresen et al., 2002 
), and the multiple basic sequence in the Rac1 C-terminal region also mediates direct interaction between PA and Rac1 (A). Previously, the polybasic motif of small GTPase was observed to nonspecifically associate with negatively charged lipid in vitro; this association does not seem to be anion specific and it depends only on the net negative charge (
Leventis and Silvius, 1998 
;
Ugolev et al., 2006 
). Polybasic peptide of Kras-4B interacts with negatively charged phospholipids such as phosphatidylserine (PS), phosphatidylinositol 4-phosphate [PI(4)P], phosphatidylinositol 4,5-bisphosphate [PI(4,5)P
2], and PA (
Leventis and Silvius, 1998 
). The Rac1 polybasic motif was also reported to interact with acidic phospholipids, including phosphatidylinositol 3-phosphate, PI(4)P, phosphatidylinositol 5-phosphate, phosphatidylinositol-(3,4,5)-trisphosphate [PI(3,4,5)P
3], and PA (
Ueyama et al., 2005 
). However, we observed that Rac1 interacts with PA-containing liposome with higher affinity than with PI(4,5)P
2, although PI(4,5)P
2 has a lower net charge. And KRas4B interacts with PI(4,5)P
2, with higher affinity than with PA (A). PA-, PS-, and PI(4,5)P
2-containing negatively charged lipid bilayers also reportedly have different binding affinity for polybasic peptide (
Yeung et al., 2006 
). These results suggest that the polybasic motif of Rac1 can interact with membrane lipid depending not only on the net negative charge but also on specific anion phospholipids. In cells, the change in negatively charged lipid content of membrane differs, and it is localized according to cellular physiological events that are regulated by kinase, inositide lipase, phospholipase, and phosphatase activation. Therefore, the consequence of altered negatively charged membrane lipids in small GTPase membrane translocation events should be demonstrated in cells. It was shown that in cells, several negatively charged phospholipids, in particular, PS, PI(4,5)P
2, and PI(3,4,5)P
3, have important roles in membrane translocation of Rac. PS involve the Rac1 detachment from local phagosome membrane surface through the potential of inner leaflet decrease by depletion or flipping of PS during the phagocytosis (
Yeung et al., 2006 
). Previously, we reported that PI(4,5)P
2 and PI(3,4,5)P
3 in combination are important for small GTPase membrane targeting (
Heo et al., 2006 
). In this article, PIP
2 and phosphatidylinositol 3,4,5-triphosphate depletion dissociate most small GTPases such as K-Ras, Rab35, and RhoE, which have a polybasic region and prenylation modification motif similar to Rac1. However, in Rac1, depletion of both PI(4,5)P
2 and PI(3,4,5)P
3 triggered only a minor reduction in plasma membrane localization. This suggests that another negatively charged lipid contributes to Rac1 membrane targeting. It was known that PI(4,5)P
2 recruited vinculin, α-actinin, and syndecan-4 and that it induced actin polymerization and was found to be essential for the formation of focal adhesions (
Fukami et al., 1992 
;
Gilmore and Burridge, 1996 
). Moreover, PA activates phosphatidylinositol-4-phosphate 5-kinase and can generate PI(4,5)P
2 (
Jenkins et al., 1994 
). However, in the present study, in vitro liposome binding analysis showed that Rac1 did not interact with PI(4,5)P
2-containing vesicles (A), and PI(4,5)P
2 treatment did not induce cell spreading (). These data suggest that PI(4,5)P
2 is not involved in Rac1 membrane translocation in the integrin signaling pathway. An investigation of the role of PI(3,4,5)P3 in Rac activity showed that phosphatidylinositol 3-kinase (PI3K) inhibitors and dominant-negative PI3K mutants reduce Rac-GTP loading. PI(3,4,5)P
3 is involved in Rac-GEF activation such as Vav, Sos, Tiam, PIX, SWAP-70, and P-Rex families (
Welch et al., 2003 
). And PI(3,4,5)P
3 can also bind directly to Rac in vitro, and it can facilitate GTP loading through the dissociation of GDP and Rac (
Missy et al., 1998 
). However, PI(3,4,5)P
3 preferably binds to and stabilizes the nucleotide-free form of Rac rather than its GTP-loaded form (
Missy et al., 1998 
). It was previously shown that platelet-derived growth factor-induced Rac-dependent lamellipodia formation is inhibited by PI3K inhibition but that V12-Rac1 can override this inhibitory effect (
Hawkins et al., 1995 
). This suggests that PI(3,4,5)P
3 is important for Rac GTP loading but that it is not involved in the targeting of Rac. However, PA did not affect Rac-GTP loading, and it induced Rac translocation, and the V12-Rac1 mutant did not restore the inhibition of lamellipodia formation caused by blocking PLD activity (data not shown). These findings suggest that PI(3,4,5)P
3 is involved in Rac-GTP loading and that PA is involved in Rac targeting for downstream effector activation. The spatial and temporal control of Rac activation is important in many cellular functions, such as cell migration, phagocytosis, cytokinesis, and superoxide production (
Bishop and Hall, 2000 
). Coincidentally, PLD and PI3K also are activated during these cellular process, and they are critical for the cellular functions required for the localization of Rac function (
Santy and Casanova, 2001 
;
Iyer et al., 2004 
). These findings suggest that the lipid second messengers PA and PI(3,4,5)P
3 can cooperatively regulate localized Rac functions in a sophisticated manner by regulating GDP/GTP exchange and membrane targeting.
In the present study, we found a new signaling pathway that bridges lipid second messenger PA and small GTPase Rac, and we show that this pathway is part of the regulatory mechanism that underlies integrin-mediated cell spreading and migration involving actin cytoskeletal rearrangement ( and Supplemental Figure S4). Integrin-mediated cell spreading and migration are essential for many diverse physiological processes, in particular, when inappropriate these cellular functions can cause cancer metastasis and tumor invasion; thus, they are the subjects of intense research scrutiny. αvβ3 integrins are up-regulated in invasive cancer cells and in angiogenic endothelial cells, and metastatic potential has been correlated with their expression. Moreover, integrins are known to guide matrix degradation and the activities of proteolytic enzymes such as matrix metalloproteinase (MMP)-2 and MMP-9 (
Hood and Cheresh, 2002 
). Previously, it was suggested that PLD is also involved in cancer progression and metastasis, and elevated PLD expression and PLD activity have been reported in breast cancer, gastric, and prostate cancer tissues (
Reich et al., 1995 
;
Uchida et al., 1999 
;
Noh et al., 2000 
). Moreover, PLD was found to stimulate cell protrusions in v-Src–transformed cells (
Shen et al., 2002 
); interestingly, highly migrating and invading MDA-MB-231 human breast cancer cells have exceptionally high PLD activities, whereas MCF-7 breast cancer cells have relatively little (
Sliva et al., 2002 
;
Zhong et al., 2003 
). Although it has been suggested that PLD is involved in cancer motility and invasion, its relation with integrin receptor and the mode of action of PLD activity in cancer metastasis are still poorly understood. In the present study, we found that PLD activity is elevated by integrin receptor signaling pathway in OVCAR-3 cells (). Furthermore, PLD block was found to inhibit integrin-mediated Rac translocation in and the spreading and migration of OVCAR-3 cells ( and ). This suggests that the PLD–PA–Rac pathway plays an important role in the metastasis of cancer cells, and it might provide a means for integrin and PLD-mediated cancer metastasis. In addition to integrin signaling, PLD and Rac have been found to be involved in diverse receptor signaling pathways. PA is known to regulate diverse physiological processes, such as, morphological change, migration, mitogenesis, phagocytosis, superoxide production, and axonal growth. (
Cockcroft, 2001 
;
Iyer et al., 2004 
;
Watanabe et al., 2004 
;
Lehman et al., 2006 
). Coincidentally with PA, Rac has also been found to be critical required for these cellular functions (
Etienne-Manneville and Hall, 2002 
). Actin cytoskeletal rearrangements are centrally involved in many cellular functions, and in particular, cell migration, phagocytosis, and axonal growth require a sophisticated form of localized actin cytoskeletal regulation. Although the perhaps obvious relationship between PLD and Rac functions in these cellular functions has not been proven, it has been reported that PLD and Rac are commonly activated during phagocytosis and that PLD and Rac are localized to actin enriched phagosome surfaces (
Ueyama et al., 2005 
;
Lehman et al., 2006 
). Moreover, during axonal growth, PLD and Rac have been commonly found to positively regulate axonal growth. In addition, PLD2 and F-actin are colocalized in growth cones and Rac is localized in lamellipodia-rich areas of growth cones during axonal growth (
Threadgill et al., 1997 
;
Nikolic et al., 1998 
;
Watanabe et al., 2004 
). These observations suggest that the PLD/PA/Rac pathway might be essential and general mechanism that underlies diverse cellular functions that involve Rac.
In summary, our findings show that PLD activity is regulated during integrin signaling and that this activation is important for integrin-mediated cell spreading and migration. We describe for the first time an endogenous regulatory pathway that controls GTP-Rac membrane translocation via direct interaction between Rac and the PLD product PA, and we demonstrate that this interaction is important for GTP-Rac1 translocation and Rho-GDI dissociation, which triggers downstream PAK activation, lamellipodia formation, cell spreading, and migration. Our results may explain the mechanisms underlying the functions of polarized cells in many systems, where precise spatiotemporal control of Rac is required. Moreover, our identification of the PLD–PA–Rac translocation pathway opens the way for further studies on the role of PA in Rac signaling in diverse cellular environments.